VRTX Stock Ownership Activity

VERTEX PHARMACEUTICALS INC 13F holders

1 value investing guru has made changes to the VERTEX PHARMACEUTICALS INC (VRTX) position according to the gurus' latest SEC quarterly report(s). The number of VRTX shares has been increased by 1 super investor(s).

Which gurus or hedge funds are buying VRTX now?

According to the latest SEC filing(s) VERTEX PHARMACEUTICALS INC (VRTX) has been bought by B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (added shares +3.16%).

To see more about who is investing in VERTEX PHARMACEUTICALS INC (VRTX), please go to the VRTX ownership page.

2026 Q1 (1 result)
B. Tweedy, Ch. Browne
+3.16%
+1,239
+0.04%
1.43%
Current price: $428.34 4.08% Reported price*: $446.54
2025 Q4 (1 result)
B. Tweedy, Ch. Browne
+0.21%
+83
+0.00%
1.43%
Current price: $428.34 5.52% Reported price*: $453.36
2025 Q3 (1 result)
B. Tweedy, Ch. Browne
+4.86%
+1,812
+0.06%
1.33%
Current price: $428.34 9.37% Reported price*: $391.64
2025 Q2 (1 result)
B. Tweedy, Ch. Browne
-2.77%
-1,063
-0.04%
1.54%
Current price: $428.34 3.79% Reported price*: $445.20
2025 Q1 (1 result)
B. Tweedy, Ch. Browne
-5.70%
-2,315
-0.10%
1.65%
Current price: $428.34 11.65% Reported price*: $484.82
2024 Q4 (2 results)
B. Tweedy, Ch. Browne
-24.20%
-12,969
-0.35%
1.10%
John Armitage
-100.00%
-124,045
-0.67%
0.00%
Current price: $428.34 6.37% AVG reported price*: $402.70
2024 Q3 (2 results)
John Armitage
buy
+124,045
+0.58%
0.00%
B. Tweedy, Ch. Browne
-1.37%
-746
-0.02%
1.19%
Current price: $428.34 7.90% AVG reported price*: $465.08
2024 Q2 (1 result)
B. Tweedy, Ch. Browne
-18.52%
-12,353
-0.27%
1.17%
Current price: $428.34 8.61% Reported price*: $468.72
2024 Q1 (1 result)
B. Tweedy, Ch. Browne
-0.10%
-65
-0.00%
1.31%
Current price: $428.34 2.47% Reported price*: $418.01
2023 Q4 (1 result)
B. Tweedy, Ch. Browne
-10.99%
-8,240
-0.16%
1.33%
Current price: $428.34 5.27% Reported price*: $406.89
2023 Q3 (1 result)
B. Tweedy, Ch. Browne
buy
+75,004
+1.40%
1.40%
Current price: $428.34 23.18% Reported price*: $347.74
2023 Q1 (1 result)
Parnassus Investments
-100.00%
-239,912
-1.49%
0.00%
Current price: $428.34 48.33% Reported price*: $288.78
2022 Q4 (1 result)
Parnassus Investments
-8.42%
-22,055
-0.14%
0.00%
Current price: $428.34 48.33% Reported price*: $288.78
2022 Q2 (1 result)
Parnassus Investments
-54.16%
-309,518
-1.93%
1.64%
Current price: $428.34 52.01% Reported price*: $281.79
2022 Q1 (1 result)
Parnassus Investments
-7.74%
-47,953
-0.23%
2.77%
Current price: $428.34 64.13% Reported price*: $260.97
2021 Q4 (1 result)
Parnassus Investments
buy
+619,438
+2.51%
2.51%
Current price: $428.34 95.05% Reported price*: $219.60
2016 Q1 (1 result)
Ole Andreas Halvorsen
-100.00%
-1,421,673
-0.79%
0.00%
Current price: $428.34 240.41% Reported price*: $125.83
2015 Q4 (1 result)
Ole Andreas Halvorsen
+5.74%
+77,209
+0.04%
0.00%
Current price: $428.34 240.41% Reported price*: $125.83
2015 Q3 (1 result)
Ole Andreas Halvorsen
-25.52%
-460,722
-0.18%
0.54%
Current price: $428.34 311.31% Reported price*: $104.14
2015 Q2 (1 result)
Ole Andreas Halvorsen
+1.98%
+35,036
+0.02%
0.84%
Current price: $428.34 246.89% Reported price*: $123.48
2015 Q1 (1 result)
Ole Andreas Halvorsen
+131.63%
+1,005,950
+0.46%
0.81%
Current price: $428.34 263.09% Reported price*: $117.97
2014 Q4 (1 result)
Ole Andreas Halvorsen
buy
+764,200
+0.42%
0.42%
Current price: $428.34 260.56% Reported price*: $118.80
24 of 24

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.